Shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as GBX 1,778.60 ($21.93) and last traded at GBX 1,772 ($21.85), with a volume of 430 shares changing hands. The stock had previously closed at GBX 1,756.80 ($21.66).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Up 0.9 %
The company has a current ratio of 9.42, a quick ratio of 9.27 and a debt-to-equity ratio of 0.04. The business’s fifty day moving average price is GBX 1,664.11 and its 200 day moving average price is GBX 1,600.47. The company has a market capitalization of £5.24 billion and a P/E ratio of -1,610.91.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
Recommended Stories
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Oracle Announces Game-Changing News for the AI Industry
- Earnings Per Share Calculator: How to Calculate EPS
- Netflix Adds 19 Million Subscribers, Growth Is Far For Over
- Stock Dividend Cuts Happen Are You Ready?
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.